Vioxx in the news, WIRED News

Wired News

Web Help for the Voting Disabled - ...ug Administration told Merck that it requires further safety and efficacy data before it will approve its successor drug to now defunct pain reliever Vioxx, said the pharmaceutical maker. Most analysts and doctors were expecting the FDA to seek additional information before approving Arcoxia because...
Rants Raves - ...@freesurf.ch) As is the practice with all pharmaceutical companies when a new medication is being developed, the effects and possible side effects of Vioxx have been tested in Merck laboratories on thousands of laboratory animals (Vioxx: How Safe Is FDA Approval? Oct. 3, 2004). Either these tests sh...
Antidepressants and Suicidal Kids - ...me when it faces withering criticism for not acting sooner on antidepressants, and for the shortage of flu vaccine and the high-profile withdrawal of Vioxx for safety concerns. Congressional investigations have focused on allegations the agency silenced its own employees who tried to raise safety co...
Inhale Some Drugs, Feel Better - ...g inflammatory responses that cause arthritis joint pain. The move follows the withdrawal of one such drug, rofecoxib -- marketed under names such as Vioxx, Foldox or Meoroxx -- after its manufacturer, Merck Co., discovered that the medicine doubled the risk of heart attacks and strokes when taken ...
Rants Raves - ...icult issue, but the Food and Drug Administration is already one of the more stringent agencies when approving drugs for its country's citizens' use (Vioxx: How Safe Is FDA Approval?, Oct. 3, 2004). There are many examples of drugs being approved for use in Europe that were not approved by the FDA a...
Vioxx: How Safe Is FDA Approval? - Vioxx: How Safe Is FDA Approval? The problems with Vioxx, taken off the market last week, raise questions about the Food and Drug Administration's safety review process. Observers say longer clinical trials should be required. Associated Press 10:18 a.m. Oct. 3, 2004 PDT WASHINGTON -- Americans shou
Street Takes Breather and Profits - ...K) dropped another $1.10 to $74 as investors again punished its shares after an article in Tuesday's New York Times questioned the safety of its drug Vioxx and also that of Celebrex, which is made by Pharmacia and co-marketed by Pfizer. Pharmacia (PHA) slipped 76 cents to $48.74 and Pfizer (PFE) fel...
'Musical Chairs' on Wall Street - ...h lost 2 to 69-1/2 after analysts said they were concerned that a study had cast some doubt on the safety of the company's blockbuster arthritis drug Vioxx. The Standard Poor's 500 index dropped 12.49 points, or 0.85 percent, to 1,452.43....
University Sues Over Drug Patent - ...was introduced in 1999 and garnered sales of $1.5 billion the same year, making it the world's fastest-selling new medicine. A second Cox-2 medicine, Vioxx, was launched later in 1999 by No. 1 U.S. drugmaker Merck Co. and had global sales of $472 million. New Jersey-based Merck was not named in the...
Headaches for Super-Aspirin? - ...Institute in London. Read ongoing Med-Tech coverage Two COX-2 inhibitors have been approved by the FDA -- Monsanto's Celecoxib (Celebrex) and Merck's Vioxx, known generically as rofecoxib. Many others are in the works. The drugs are designed to be an improvement on old-fashioned aspirin and related ...

*This site is for informational purposes only please consult proper authorities for proper diagnosis.